Analysis of RNA sequencing data from The Cancer Genome Atlas Prostate Adenocarcinoma (TCGA PRAD) cohort [24] reveals GALNT7 gene expression levels are 1.9 fold increased in prostate tumours relative to normal prostate tissue (n = 549, p < 0.001) (Fig. 1A). The gene discussed is GALNT7; the disease is prostate adenocarcinoma.